Results 61 to 70 of about 2,204,360 (120)

A 7-mm Covered TIPS Reduces Hepatic Encephalopathy Without Increasing Rebleeding in Cirrhotic Patients With Small Liver: A Randomized Study. [PDF]

Liver Int
Liu F, Zhang K, Zhang Y, He Q, Meng M, Ma X, Zhu B, Wu Y, An L, Lv Y, Lin F, Zhang K, Liu B, Chang X, Ding H, Liu J, Chen Y, Yang Y.   +17 more
europepmc   +1 more source

Serum AKR1B10 in Early Hepatocellular Carcinoma: Superiority to AFP or Disease-Spectrum-Dependent Complementarity? [PDF]

Liver Int
Tian Y, Li W.
europepmc   +1 more source

Polydeoxyribonucleotide Enhances Liver Regeneration Following Partial Hepatectomy in Rats in Association with Growth Factor and A_2A Receptor Signaling. [PDF]

Medicina (Kaunas)
Ko IG, Choi HI, Park SB, Shin HP, Jeon JW, Lee S.   +5 more
europepmc   +1 more source

β-Caryophyllene Mitigates Thioacetamide-Induced Liver Fibrosis Through CB2-Mediated Suppression of Necroptosis: A Therapeutic Investigation. [PDF]

Pharmacol Res Perspect
Eddin LB, Arunachalam S, Lubbad L, Hammad FT, Adeghate E, Subramanya S, Ojha S.   +6 more
europepmc   +1 more source

Reverse bioengineering of the liver: developmental principles for next-generation liver-on-a-chip systems. [PDF]

Commun Biol
Kamei KI.
europepmc   +1 more source

Compound Abrus cantoniensis Extract Alleviates AFB₁-Induced Liver Injury by Regulating PI3K-AKT Pathway and Gut Microbiota/Butyrate Metabolism. [PDF]

Adv Sci (Weinh)
Hu H, Cheng M, Zheng S, Liu H, Wei X, Yang W, Yang H, Yuan L, Jiang L, Chen J, Zhao L, Guo Y, Si H.   +12 more
europepmc   +1 more source

Acute on chronic liver failure in erythropoietic protoporphyria: A case report and review of the literature. [PDF]

Hepatol Forum
Viswanath A, Thomas RT, Kumar E S, Zachariah UG, Jose SK, Thomas M, Kodiatte TA.   +6 more
europepmc   +1 more source

Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction. [PDF]

Aging Cell
Yang K, Jian Y, Pang F, Ying M, Yang Q, Liu N, Wang S, Wu Y.   +7 more
europepmc   +1 more source

Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs. [PDF]

World J Methodol
Pan HY, Chen WW, Liang JX, Sheng YY, Zhang WJ, Zhu XW, Wang SY, Yang GH, Liu Y, Xu TC.   +9 more
europepmc   +1 more source

Inhibition of Acetylation Activity of p300/CBP Ameliorates Hepatic Steatosis Through Downregulation of ACSL4. [PDF]

Liver Int
Cai LY, Guan YP, Hu JH, Sun CY, Ding CH, Zhang X, Zeng X, Xie WF.   +7 more
europepmc   +1 more source